NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market
Management believes uplisting has the potential to provide shareholders with improved liquidityRequires NRx Pharmaceuticals to meet certain listing requirementsCompany has advised NASDAQ that current shares outstanding is 15.7 million